Scientists are studying the combination of BPC-157 and TB-500 for their potential synergistic effects on tissue regeneration. Preclinical animal models show promising results in tendon and muscle repair.
Combining BPC-157, TB-500, and GHK-Cu creates a research-backed blend targeting tissue repair, collagen support, and skin health. Each peptide plays a distinct role in the cellular repair cascade.
Retatrutide simultaneously targets three metabolic receptors — GLP-1, GIP, and glucagon — showing up to 24% average body weight reduction in Phase 2 clinical trials. Phase 3 studies are now underway.
Studied since the 1970s, GHK-Cu is a copper-binding tripeptide associated with collagen synthesis, wound healing, and anti-aging biology. Its concentration naturally declines with age.
CJC-1295 and Ipamorelin are two of the most studied peptides in growth hormone research. Together they create a complementary stimulus for GH release — one sustained, one pulsatile.
All articles on the House of Peptides blog are strictly for educational and informational purposes. The content does not constitute medical advice, diagnosis, or treatment recommendations. The peptides discussed are research compounds not approved by the FDA or other regulatory agencies for human use. Never use any compound without consulting a licensed healthcare professional.
